Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

Published:2011-06-01 Issue:2 Volume:11 Page:131-149
ISSN:1871-5222
Container-title:Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
language:en
Short-container-title:IEMAMC

Author:

K. Jathal Maitreyee,Chen Liqun,Mudryj Maria,M. Ghosh Paramita

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization;2024-08-30

2. HER3 receptor and its role in the therapeutic management of metastatic breast cancer;Journal of Translational Medicine;2024-07-17

3. HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs;Cancer Drug Resistance;2024-04-29

4. The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer;Frontiers in Physiology;2024-03-27

5. ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity Signature;Clinical Cancer Research;2024-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP